Search - tctmd.com

Displaying 261 - 280 of 450

Sort: Relevancy | Date

News Daily News

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Caitlin E. Cox

June 13, 2014

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Industry News

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

May 23, 2014

News Daily News

Cardiac Stress Imaging at 5 Years Post-PCI Holds Prognostic Value

Caitlin E. Cox

May 14, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

May 05, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

News Industry News

Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease

April 28, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

Use of Smaller Catheters in Radial PCI Cuts Access-Site Complications

L.A. McKeown

April 15, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

April 09, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

April 02, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Industry News

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

March 27, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

Advertisement

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Nationwide Registry Shows Trends in DES Use Over a Decade

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

Cardiac Stress Imaging at 5 Years Post-PCI Holds Prognostic Value

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Renal Denervation Shows Promise in Patients Refractory to Stenting

Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Use of Smaller Catheters in Radial PCI Cuts Access-Site Complications

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content